Prostate-specific antigen levels in men aged 70 years and over: Findings from the CHAMP study

Medical Journal of Australia

Volumn 196, Issue 6, 2012, Pages 395-398

  Litchfield, Melisa J ^a   Cumming, Robert G ^b   Smith, David P ^c   Naganathan, Vasi ^a   le Couteur, David G ^a   Waite, Louise M ^a   Blyth, Fiona M ^a   Handelsman, David J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CANCER RESEARCH DIVISION   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; CANCER SCREENING; CHINA; COHORT ANALYSIS; COMMUNITY LIVING; DIGITAL RECTAL EXAMINATION; ETHNIC GROUP; GREECE; HUMAN; IMMIGRANT; IRELAND; ITALY; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; REFERENCE VALUE; SELF REPORT; UNITED KINGDOM;

AGE FACTORS; AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; MALE; NEW SOUTH WALES; PREVALENCE; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84861134205     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja11.11014     Document Type: Article

References (19)

1. Andriole GL, Crawford ED, Grub RL 3rd, et al; PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009; 360: 1310-1319.
2. Schröder FH, Hugosson J, Roobol MJ, et al; ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-1328.
3. US Preventive Services Task Force. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2008; 149: 185-191.
4. Holden CA, McLachlan RI, Pitts M, et al. Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men. Lancet 2005; 366: 218-224.
5. Oesterling JE, Jacobsen SJ, Chute CG, et al. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age specific reference ranges. JAMA 1993; 270: 860-864.
6. DeAntoni EP. Age-specific reference ranges for PSA in the detection of prostate cancer. Oncology (Williston Park) 1997; 11: 475-482, 485; discussion 485-486, 489.
7. Oesterling JE, Kumamoto Y, Tsukamoto T, et al. Serum prostate-specific antigen in a community based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol 1995; 75: 347-353.
8. He D, Wang M, Chen X, et al. Ethnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male population. Urology 2004; 63: 722-726.
9. Kehinde EO, Mojiminiyi OA, Sheikh M, et al. Agespecific reference levels of serum prostate-specific antigen and prostate volume in healthy Arab men. BJU Int 2005; 96: 308-312.
10. DeAntoni EP, Crawford DE, Oesterling JE, et al. Ageand race-specific reference ranges for prostate specific antigen from a large community-based study. Urology 1996; 48: 234-239.
11. Cumming RG, Handelsman D, Seibel MJ, et al. Cohort Profile: the Concord Health and Ageing in Men Project (CHAMP). Int J Epidemiol 2009; 38: 374-378.
12. Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549-1557; discussion 1564.
13. Kalish LA, McKinlay JB. Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSA. Urology 1999; 54: 1022-1027.
14. Porter MP, Stanford JL, Lange PH. The distribution of serum prostate-specific antigen levels among American men: implications for prostate cancer prevalence and screening. Prostate 2006; 66: 1044-1051.
15. Lee SE, Kwak C, Park MS, et al. Ethnic differences in the age-related distribution of serum prostate specific antigen values: a study in a healthy Korean male population. Urology 2000; 56: 1007-1010.
16. Morgan TO, Jacobsen SJ, McCarthy WF, et al. Agespecific reference ranges for prostate-specific antigen in black men. N Engl J Med 1996; 335: 304-310.
17. Supramaniam R, O'Connell DL, Tracey EA, Sitas F. Cancer incidence in New South Wales migrants 1991 to 2001. Sydney: The Cancer Council NSW, 2006. svc013.wic047p.server-eb.com/html/research/epidemiological/downloads/cancer_in_migrants.pdf (accessed Feb 2012).
18. Ferlay J, Shin H, Bray F, et al, editors. GLOBOCAN 2008: Cancer incidence and mortality worldwide: IARC Cancer Base No. 10. Lyon, France: International Agency for Research on Cancer, 2010.
19. Weber M, Banks E, Smith DP, et al. Cancer screening among migrants in an Australian cohort; cross sectional analyses from the 45 and Up Study. BMC Public Health 2009; 9: 144.